MedDataX Logo

Vienna Versus SARS-CoV-2 Virus Study

NCT ID: NCT04407429

Last Updated: 2020-05-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

12000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-05-27

Study Completion Date

2021-06-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study examines the seroprevalence against SARS-CoV-2 in health care workers and patients at the Vienna General Hospital.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study consists of 2 parts: a longitudinal study enrolling 3,000 health care professionals at the Vienna General Hospital testing their antibody status 6 times over a period of 12 months (Cohort A), and a serial cross-sectional study of 3,000 patients (i.e., a total of 9,000 patients) admitted to the Vienna General Hospital for non-COVID-19-related symptoms at 3 different time points during this pandemic (Cohort B).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SARS-CoV-2 COVID-19

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

COVID-19 SARS-CoV-2 Immunity Antibodies Virus Respiratory Virus Immunoglobulins

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Health care workers

Physicians, Nursing staff, Midwives, Medical-technical assistants (including medical, therapeutic and diagnostic healthcare staff, and medical and nursing assistants), administrative personnel with patient contact

Laboratory Analyses

Intervention Type DIAGNOSTIC_TEST

Storage of serum for SARS-CoV-2-antibodies and biomarkers

Patients

Patients admitted for non-COVID related symptoms to the Vienna General Hospital with available residual serum samples.

Laboratory Analyses

Intervention Type DIAGNOSTIC_TEST

Storage of serum for SARS-CoV-2-antibodies and biomarkers

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laboratory Analyses

Storage of serum for SARS-CoV-2-antibodies and biomarkers

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Physicians
* Nursing staff
* Midwives
* Medical-technical assistants (including medical, therapeutic and diagnostic healthcare staff, and medical and nursing assistants)
* Administrative personnel with patient contact


● Patients with available residual serum samples

Exclusion Criteria

* Not employed at the Medical University of Vienna or the Vienna General Hospital
* No signed informed consent

Cohort B:


● Serum samples from COVID-19 triage units at the Vienna General Hospital
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christian Hengstenberg

Univ.-Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christian Hengstenberg, Univ.-Prof.

Role: PRINCIPAL_INVESTIGATOR

Medical University of Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Vienna

Vienna, , Austria

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christian Hengstenberg, Univ.-Prof.

Role: CONTACT

Phone: +43 1 40400

Email: [email protected]

Thomas A Zelniker, DDr.

Role: CONTACT

Phone: +43 1 40400

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christian Hengstenberg, Univ.-Prof.

Role: primary

Thomas A Zelniker, DDr.

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Riesenhuber M, Nitsche C, Binder CJ, Schernhammer ES, Stamm T, Jakse F, Anwari E, Hamidi F, Haslacher H, Perkmann T, Hengstenberg C, Zelniker TA. Comparison of the prevalence of SARS-CoV-2 nucleoprotein antibodies in healthcare workers and an unselected adult and paediatric all-comer patient population: insights from a longitudinal study of healthcare workers and concurrent serial cross-sectional studies of patients at an academic medical centre in Austria. BMJ Open. 2023 Jan 18;13(1):e063760. doi: 10.1136/bmjopen-2022-063760.

Reference Type DERIVED
PMID: 36657754 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EK 1387/2020

Identifier Type: -

Identifier Source: org_study_id